Evidence map›Paper›PMID 41908347›Full record

ArticleJournal of clinical practice and research2026

Impact of Oxacillinase-48 (OXA-48) and New Delhi Metallo-β-Lactamase (NDM) Co-existence on Mortality in Critically Ill Patients with

Merve Yıldız Kayar, Esma Eryılmaz Eren, Süleyman Yalçın, Yasemin Ay Altıntop, Esma Saatçi, Kamil Deveci, Emin Silay, İlhami Çelik

Abstract read
In one paragraph

Article in Journal of clinical practice and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Merve Yıldız KayarDepartment of Infectious Disease and Clinical Microbiology, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
Esma Eryılmaz ErenDepartment of Infectious Disease and Clinical Microbiology, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
Süleyman YalçınMinistry of Health, General Directorate of Public Health, National Molecular Microbiology Reference Laboratory, Ankara, Türkiye.
Yasemin Ay AltıntopDepartment of Medical Microbiology, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
Esma SaatçiDepartment of Medical Microbiology, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
Kamil DeveciIntensive Care Unit, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
Emin SilayDepartment of Anesthesia and Resuscitation, Kayseri City Training and Research Hospital, Kayseri, Türkiye.
İlhami ÇelikDepartment of Infectious Disease and Clinical Microbiology, Kayseri City Training and Research Hospital, Kayseri, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Carbapenem-resistant Materials and Methods: This prospective study included 83 adult patients with CRKp bacteremia at Kayseri City Training and Research Hospital between September 2023 and March 2024. The control group consisted of patients without infection from the same hospital units. Pathogens were identified using the Vitek 2 system. Susceptibility to ceftazidime-avibactam and colistin was determined using disk methods. Carbapenemase genes were detected by polymerase chain reaction (PCR). Results: In the multivariable logistic regression analysis, central venous catheter use, rectal colonization, and prior piperacillin-tazobactam use were identified as significant risk factors for CRKp bacteremia. Among the isolates, 95% carried OXA-48, 48.2% carried NDM, and 3.6% carried Conclusion: This study demonstrates that OXA-48 remains the most prevalent carbapenemase type in CRKp bloodstream infections in Türkiye, while NDM is increasing rapidly and frequently co-occurs with OXA-48, worsening clinical outcomes. Strengthening infection control measures, promoting the prudent use of antibiotics, and ensuring access to new treatment agents are crucial for reducing the spread and impact of CRKp infections.

Indexed as

CarbapenemaseNew Delhi metallo-β-lactamase-1 (NDM)oxacillinase-48 (OXA-48)

Identifiers

PMID41908347
PMCPMC13022838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.